The 2022 audit cycle is coming to a close. CMS issued its last engagement letters for 2022 program audits at the end of...

Diabetes is an epidemic that drives a significant amount of medical cost. Eleven percent of the United States’...

At Elixir, whole member health is at the heart of our formulary strategy and drug management practices. As we prepare...

Specialty medications are not only used to treat complex conditions, they are themselves complex in nature. Some have...

On August 16th, 2022, President Biden signed into law H.R. 5376, a budget reconciliation measure known as the Inflation...

According to the Centers for Disease Control and Prevention (CDC), there were as many as 14,000 flu-related deaths and...

Digital therapeutics (DTx) uses software programs to prevent, manage or treat diseases. They may be used with or...

Specialty medications continue to be a large source of drug spend, in particular biologic drugs. Biosimilars pose an...

Cystic fibrosis (CF) is a rare genetic disorder that affects one in 3,900 live births. There are approximately 30,000...

On June 7, 2022, the Centers for Medicare and Medicaid Services (CMS) released the 2021 Part C and Part D Program Audit...